EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The role of tumor microenvironment and immune cell crosstalk in triple-negative breast cancer (TNBC): Emerging therapeutic opportunities

Hussein Sabit, Amro Adel, Mariam M Abdelfattah, Rehab M Ramadan, Mahmoud Nazih, Shaimaa Abdel-Ghany, Ahmed El-Hashash, Borros Arneth

Cancer Letters · 2025-09 · 628 · 217865

DOI: 10.1016/j.canlet.2025.217865 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Letters, 2025-09. Verfasst von Hussein Sabit und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology, College of Biotechnology, Misr University for Science and Technology, P.O. Box 77, Giza, 3237101, Egypt. Electro…. Hauptthemen laut MEDLINE: Tumor Microenvironment, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 111-mal zitiert (Crossref) und nennt 359 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) is an aggressive subtype characterized by its lack of estrogen, progesterone, and HER2 receptors, leading to limited treatment options and poor prognosis. This review synthesizes current research on the tumor microenvironment (TME) and immune cell crosstalk in TNBC to identify emerging therapeutic opportunities. The TME in TNBC is a complex ecosystem comprising immune cells, fibroblasts, and extracellular matrix components, which significantly influence tumor growth and metastasis. Single-cell RNA sequencing reveals T-cell heterogeneity and identifies prognostic genes. Regulatory T cells (Tregs) play a key role in immunosuppression, with thymidine kinase-1 (TK1) identified as a potential therapeutic target. MUC1-C and CXCL9 modulate the TME, impacting T-cell depletion and macrophage differentiation. Spatial analysis highlights the importance of cell-to-cell interactions in predicting recurrence. Epithelial-mesenchymal transition (EMT) and thermogenesis also influence the TME, while epigenetic modifications, such as HDAC inhibition, can induce pyroptosis and enhance immune cell recruitment. Integrating genomic information with TME analysis is crucial for developing personalized treatments, considering racial disparities in immune infiltration. Emerging therapies targeting immune checkpoints, modulating Treg activity, and inducing pyroptosis hold promise for improving TNBC patient outcomes. Future research should focus on multi-omics data, spatial transcriptomics, and patient-derived models to refine therapeutic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentTriple Negative Breast NeoplasmsHumansFemaleEpithelial-Mesenchymal TransitionCell Communication

Stichwörter der Autor:innen

(ADC)(AI)(MDSCs)(PARPi)(TME)AR/Scr/Pl3-KAnti-androgen therapiesAntibody-drug conjugateArtificial intelligenceImmunotherapyMyeloid-derived suppressor cellsPARP inhibitorsPrognostic markersTargeted therapyTumor microenvironment

Autor:innen und Institutionen

  • Department of Medical Biotechnology, College of Biotechnology, Misr University for Science and Technology, P.O. Box 77, Giza, 3237101, Egypt. Electronic address: hussein.sabit@must.edu.eg.
  • Department of Pharmaceutical Biotechnology, College of Biotechnology, Misr University for Science and Technology, P.O. Box 77, Giza, 3237101, Egypt.
  • Department of Environmental Biotechnology, College of Biotechnology, Misr University for Science and Technology, P.O. Box 77, Giza, 3237101, Egypt.
  • Al Ryada University for Science and Technology (RST), ElMehwar ElMarkazy-2, Cairo - Alex desert RD K92, Sadat City, 16504, Egypt; Scientific Office, Egyptian Society of Pharmacogenomics and Personalized Medicine (ESPM),…
  • Elizabeth City State campus of the University of North Carolina (UNC), NC, 27909, USA.
  • Institute of Laboratory Medicine and Pathobiochemistry, Molecular Diagnostics, Hospital of the Universities of Giessen and Marburg (UKGM), Philipps University Marburg, Baldingerstr. 1, Marburg, 35043, Germany; Institute…

Zitieren

APA

Sabit, H., Adel, A., Abdelfattah, M. M., Ramadan, R. M., Nazih, M., Abdel-Ghany, S., El-Hashash, A., & Arneth, B. (2025). The role of tumor microenvironment and immune cell crosstalk in triple-negative breast cancer (TNBC): Emerging therapeutic opportunities. Cancer Letters, 628, 217865. https://doi.org/10.1016/j.canlet.2025.217865

Vancouver

Sabit H, Adel A, Abdelfattah MM, Ramadan RM, Nazih M, Abdel-Ghany S, et al. The role of tumor microenvironment and immune cell crosstalk in triple-negative breast cancer (TNBC): Emerging therapeutic opportunities. Cancer Letters. 2025;628:217865. doi:10.1016/j.canlet.2025.217865

BibTeX
@article{Sabit2025,
  author = {Sabit, Hussein and Adel, Amro and Abdelfattah, Mariam M and Ramadan, Rehab M and Nazih, Mahmoud and Abdel-Ghany, Shaimaa and El-Hashash, Ahmed and Arneth, Borros},
  title = {The role of tumor microenvironment and immune cell crosstalk in triple-negative breast cancer (TNBC): Emerging therapeutic opportunities},
  journal = {Cancer Letters},
  year = {2025},
  volume = {628},
  pages = {217865},
  doi = {10.1016/j.canlet.2025.217865}
}
Kostenlos starten →